Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial
Event:
ESC Asia 2022 with APSC & AFC
Topic:
Treatment
Session:
Coronary Artery Disease / Acute Coronary Syndromes